In contrast to ceramides, epidemiology studies suggest beneficial effects of PUFAs in MS [68], in particular linolenic acid, which was neuroprotective in EAE mice [23], and is generated via cytochrome B5 dependent stearoyl CoA desaturases and other fatty acid desaturases. This evidence concerns the gene CYB5A and myeloid sarcoma.